Actively Recruiting
A Long-term Follow-up Study in Participants Who Received CS-101
Led by Children's Hospital of Fudan University · Updated on 2025-09-10
5
Participants Needed
1
Research Sites
154 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-03 (NCT06065189)
CONDITIONS
Official Title
A Long-term Follow-up Study in Participants Who Received CS-101
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must be between 3 and 17 years old
- Participants (or legally authorized representative or guardian) must sign and date the informed consent form
- Participants must have received CS-101 infusion in the previous CS-101-03 study
You will not qualify if you...
- There are no exclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China, 201102
Actively Recruiting
Research Team
X
Xiaowen Zhai, M.D.
CONTACT
Z
Zifeng Li, M.S.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here